Blood Culture Pathology Tests- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 152 Pages

Report ld: 3901067

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Blood Culture Pathology Tests was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

A blood culture is a medical laboratory test used to detect the presence of microorganisms, such as bacteria and fungi, in a patient"s bloodstream.

North American market for Blood Culture Pathology Tests was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Blood Culture Pathology Tests was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Blood Culture Pathology Tests was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Blood Culture Pathology Tests include Biobase Biotech, Scenker Biological Technology, Bulldog Bio, Anaerobe Systems, Himedia Laboratories, Autobio Diagnostics, Axiom Laboratories, Iridica, Biosystems, BINDER GmBH, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Blood Culture Pathology Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood Culture Pathology Tests by region & country, by Type, and by Application.

The Blood Culture Pathology Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Culture Pathology Tests.

Market Segmentation

Report Metric
Details
Report Title
Blood Culture Pathology Tests- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Market Size Available for Years
2025-2031
Global Blood Culture Pathology Tests Companies Covered
Biobase Biotech
Scenker Biological Technology
Bulldog Bio
Anaerobe Systems
Himedia Laboratories
Autobio Diagnostics
Axiom Laboratories
Iridica
Biosystems
BINDER GmBH
Terumo Corporation
BD
BioMérieux
Thermo Fisher Scientific
Danaher
Luminex
Bruker
Roche
Mikroscan Technologies
Labotronics
Hardy Diagnostics
OpGen
Meditech Technologie
Global Blood Culture Pathology Tests Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Culture Pathology Tests Market, Segment by Type
Instruments
Consumables
Others
Global Blood Culture Pathology Tests Market, Segment by Application
Bacteremia
Fungemia
Mycobacterial Detection
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Culture Pathology Tests company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blood Culture Pathology Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blood Culture Pathology Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Blood Culture Pathology Tests Product Introduction
    1.2 Global Blood Culture Pathology Tests Market Size Forecast (2020-2031)
    1.3 Blood Culture Pathology Tests Market Trends & Drivers
        1.3.1 Blood Culture Pathology Tests Industry Trends
        1.3.2 Blood Culture Pathology Tests Market Drivers & Opportunity
        1.3.3 Blood Culture Pathology Tests Market Challenges
        1.3.4 Blood Culture Pathology Tests Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Blood Culture Pathology Tests Players Revenue Ranking (2024)
    2.2 Global Blood Culture Pathology Tests Revenue by Company (2020-2025)
    2.3 Key Companies Blood Culture Pathology Tests Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Blood Culture Pathology Tests Product Offered
    2.5 Key Companies Time to Begin Mass Production of Blood Culture Pathology Tests
    2.6 Blood Culture Pathology Tests Market Competitive Analysis
        2.6.1 Blood Culture Pathology Tests Market Concentration Rate (2020-2025)
        2.6.2 Global 5 and 10 Largest Companies by Blood Culture Pathology Tests Revenue in 2024
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Culture Pathology Tests as of 2024)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Instruments
        3.1.2 Consumables
        3.1.3 Others
    3.2 Global Blood Culture Pathology Tests Sales Value by Type
        3.2.1 Global Blood Culture Pathology Tests Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Blood Culture Pathology Tests Sales Value, by Type (2020-2031)
        3.2.3 Global Blood Culture Pathology Tests Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Bacteremia
        4.1.2 Fungemia
        4.1.3 Mycobacterial Detection
    4.2 Global Blood Culture Pathology Tests Sales Value by Application
        4.2.1 Global Blood Culture Pathology Tests Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Blood Culture Pathology Tests Sales Value, by Application (2020-2031)
        4.2.3 Global Blood Culture Pathology Tests Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region
    5.1 Global Blood Culture Pathology Tests Sales Value by Region
        5.1.1 Global Blood Culture Pathology Tests Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Blood Culture Pathology Tests Sales Value by Region (2020-2025)
        5.1.3 Global Blood Culture Pathology Tests Sales Value by Region (2026-2031)
        5.1.4 Global Blood Culture Pathology Tests Sales Value by Region (%), (2020-2031)
    5.2 North America
        5.2.1 North America Blood Culture Pathology Tests Sales Value, 2020-2031
        5.2.2 North America Blood Culture Pathology Tests Sales Value by Country (%), 2024 VS 2031
    5.3 Europe
        5.3.1 Europe Blood Culture Pathology Tests Sales Value, 2020-2031
        5.3.2 Europe Blood Culture Pathology Tests Sales Value by Country (%), 2024 VS 2031
    5.4 Asia Pacific
        5.4.1 Asia Pacific Blood Culture Pathology Tests Sales Value, 2020-2031
        5.4.2 Asia Pacific Blood Culture Pathology Tests Sales Value by Region (%), 2024 VS 2031
    5.5 South America
        5.5.1 South America Blood Culture Pathology Tests Sales Value, 2020-2031
        5.5.2 South America Blood Culture Pathology Tests Sales Value by Country (%), 2024 VS 2031
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Blood Culture Pathology Tests Sales Value, 2020-2031
        5.6.2 Middle East & Africa Blood Culture Pathology Tests Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Blood Culture Pathology Tests Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Blood Culture Pathology Tests Sales Value, 2020-2031
    6.3 United States
        6.3.1 United States Blood Culture Pathology Tests Sales Value, 2020-2031
        6.3.2 United States Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Blood Culture Pathology Tests Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Blood Culture Pathology Tests Sales Value, 2020-2031
        6.4.2 Europe Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Blood Culture Pathology Tests Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Blood Culture Pathology Tests Sales Value, 2020-2031
        6.5.2 China Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Blood Culture Pathology Tests Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Blood Culture Pathology Tests Sales Value, 2020-2031
        6.6.2 Japan Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Blood Culture Pathology Tests Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Blood Culture Pathology Tests Sales Value, 2020-2031
        6.7.2 South Korea Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Blood Culture Pathology Tests Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Blood Culture Pathology Tests Sales Value, 2020-2031
        6.8.2 Southeast Asia Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Blood Culture Pathology Tests Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Blood Culture Pathology Tests Sales Value, 2020-2031
        6.9.2 India Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Blood Culture Pathology Tests Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 Biobase Biotech
        7.1.1 Biobase Biotech Profile
        7.1.2 Biobase Biotech Main Business
        7.1.3 Biobase Biotech Blood Culture Pathology Tests Products, Services and Solutions
        7.1.4 Biobase Biotech Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.1.5 Biobase Biotech Recent Developments
    7.2 Scenker Biological Technology
        7.2.1 Scenker Biological Technology Profile
        7.2.2 Scenker Biological Technology Main Business
        7.2.3 Scenker Biological Technology Blood Culture Pathology Tests Products, Services and Solutions
        7.2.4 Scenker Biological Technology Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.2.5 Scenker Biological Technology Recent Developments
    7.3 Bulldog Bio
        7.3.1 Bulldog Bio Profile
        7.3.2 Bulldog Bio Main Business
        7.3.3 Bulldog Bio Blood Culture Pathology Tests Products, Services and Solutions
        7.3.4 Bulldog Bio Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.3.5 Bulldog Bio Recent Developments
    7.4 Anaerobe Systems
        7.4.1 Anaerobe Systems Profile
        7.4.2 Anaerobe Systems Main Business
        7.4.3 Anaerobe Systems Blood Culture Pathology Tests Products, Services and Solutions
        7.4.4 Anaerobe Systems Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.4.5 Anaerobe Systems Recent Developments
    7.5 Himedia Laboratories
        7.5.1 Himedia Laboratories Profile
        7.5.2 Himedia Laboratories Main Business
        7.5.3 Himedia Laboratories Blood Culture Pathology Tests Products, Services and Solutions
        7.5.4 Himedia Laboratories Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.5.5 Himedia Laboratories Recent Developments
    7.6 Autobio Diagnostics
        7.6.1 Autobio Diagnostics Profile
        7.6.2 Autobio Diagnostics Main Business
        7.6.3 Autobio Diagnostics Blood Culture Pathology Tests Products, Services and Solutions
        7.6.4 Autobio Diagnostics Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.6.5 Autobio Diagnostics Recent Developments
    7.7 Axiom Laboratories
        7.7.1 Axiom Laboratories Profile
        7.7.2 Axiom Laboratories Main Business
        7.7.3 Axiom Laboratories Blood Culture Pathology Tests Products, Services and Solutions
        7.7.4 Axiom Laboratories Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.7.5 Axiom Laboratories Recent Developments
    7.8 Iridica
        7.8.1 Iridica Profile
        7.8.2 Iridica Main Business
        7.8.3 Iridica Blood Culture Pathology Tests Products, Services and Solutions
        7.8.4 Iridica Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.8.5 Iridica Recent Developments
    7.9 Biosystems
        7.9.1 Biosystems Profile
        7.9.2 Biosystems Main Business
        7.9.3 Biosystems Blood Culture Pathology Tests Products, Services and Solutions
        7.9.4 Biosystems Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.9.5 Biosystems Recent Developments
    7.10 BINDER GmBH
        7.10.1 BINDER GmBH Profile
        7.10.2 BINDER GmBH Main Business
        7.10.3 BINDER GmBH Blood Culture Pathology Tests Products, Services and Solutions
        7.10.4 BINDER GmBH Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.10.5 BINDER GmBH Recent Developments
    7.11 Terumo Corporation
        7.11.1 Terumo Corporation Profile
        7.11.2 Terumo Corporation Main Business
        7.11.3 Terumo Corporation Blood Culture Pathology Tests Products, Services and Solutions
        7.11.4 Terumo Corporation Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.11.5 Terumo Corporation Recent Developments
    7.12 BD
        7.12.1 BD Profile
        7.12.2 BD Main Business
        7.12.3 BD Blood Culture Pathology Tests Products, Services and Solutions
        7.12.4 BD Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.12.5 BD Recent Developments
    7.13 BioMérieux
        7.13.1 BioMérieux Profile
        7.13.2 BioMérieux Main Business
        7.13.3 BioMérieux Blood Culture Pathology Tests Products, Services and Solutions
        7.13.4 BioMérieux Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.13.5 BioMérieux Recent Developments
    7.14 Thermo Fisher Scientific
        7.14.1 Thermo Fisher Scientific Profile
        7.14.2 Thermo Fisher Scientific Main Business
        7.14.3 Thermo Fisher Scientific Blood Culture Pathology Tests Products, Services and Solutions
        7.14.4 Thermo Fisher Scientific Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.14.5 Thermo Fisher Scientific Recent Developments
    7.15 Danaher
        7.15.1 Danaher Profile
        7.15.2 Danaher Main Business
        7.15.3 Danaher Blood Culture Pathology Tests Products, Services and Solutions
        7.15.4 Danaher Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.15.5 Danaher Recent Developments
    7.16 Luminex
        7.16.1 Luminex Profile
        7.16.2 Luminex Main Business
        7.16.3 Luminex Blood Culture Pathology Tests Products, Services and Solutions
        7.16.4 Luminex Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.16.5 Luminex Recent Developments
    7.17 Bruker
        7.17.1 Bruker Profile
        7.17.2 Bruker Main Business
        7.17.3 Bruker Blood Culture Pathology Tests Products, Services and Solutions
        7.17.4 Bruker Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.17.5 Bruker Recent Developments
    7.18 Roche
        7.18.1 Roche Profile
        7.18.2 Roche Main Business
        7.18.3 Roche Blood Culture Pathology Tests Products, Services and Solutions
        7.18.4 Roche Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.18.5 Roche Recent Developments
    7.19 Mikroscan Technologies
        7.19.1 Mikroscan Technologies Profile
        7.19.2 Mikroscan Technologies Main Business
        7.19.3 Mikroscan Technologies Blood Culture Pathology Tests Products, Services and Solutions
        7.19.4 Mikroscan Technologies Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.19.5 Mikroscan Technologies Recent Developments
    7.20 Labotronics
        7.20.1 Labotronics Profile
        7.20.2 Labotronics Main Business
        7.20.3 Labotronics Blood Culture Pathology Tests Products, Services and Solutions
        7.20.4 Labotronics Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.20.5 Labotronics Recent Developments
    7.21 Hardy Diagnostics
        7.21.1 Hardy Diagnostics Profile
        7.21.2 Hardy Diagnostics Main Business
        7.21.3 Hardy Diagnostics Blood Culture Pathology Tests Products, Services and Solutions
        7.21.4 Hardy Diagnostics Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.21.5 Hardy Diagnostics Recent Developments
    7.22 OpGen
        7.22.1 OpGen Profile
        7.22.2 OpGen Main Business
        7.22.3 OpGen Blood Culture Pathology Tests Products, Services and Solutions
        7.22.4 OpGen Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.22.5 OpGen Recent Developments
    7.23 Meditech Technologie
        7.23.1 Meditech Technologie Profile
        7.23.2 Meditech Technologie Main Business
        7.23.3 Meditech Technologie Blood Culture Pathology Tests Products, Services and Solutions
        7.23.4 Meditech Technologie Blood Culture Pathology Tests Revenue (US$ Million) & (2020-2025)
        7.23.5 Meditech Technologie Recent Developments

8 Industry Chain Analysis
    8.1 Blood Culture Pathology Tests Industrial Chain
    8.2 Blood Culture Pathology Tests Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Blood Culture Pathology Tests Sales Model
        8.5.2 Sales Channel
        8.5.3 Blood Culture Pathology Tests Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Blood Culture Pathology Tests Market Trends
 Table 2. Blood Culture Pathology Tests Market Drivers & Opportunity
 Table 3. Blood Culture Pathology Tests Market Challenges
 Table 4. Blood Culture Pathology Tests Market Restraints
 Table 5. Global Blood Culture Pathology Tests Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Blood Culture Pathology Tests Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Blood Culture Pathology Tests Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Blood Culture Pathology Tests Product Type
 Table 9. Key Companies Time to Begin Mass Production of Blood Culture Pathology Tests
 Table 10. Global Blood Culture Pathology Tests Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Culture Pathology Tests as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Blood Culture Pathology Tests Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Blood Culture Pathology Tests Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Blood Culture Pathology Tests Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Blood Culture Pathology Tests Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Blood Culture Pathology Tests Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Blood Culture Pathology Tests Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Blood Culture Pathology Tests Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Blood Culture Pathology Tests Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Blood Culture Pathology Tests Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Blood Culture Pathology Tests Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Blood Culture Pathology Tests Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Blood Culture Pathology Tests Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Blood Culture Pathology Tests Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Blood Culture Pathology Tests Sales Value by Region (2020-2025) & (%)
 Table 27. Global Blood Culture Pathology Tests Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Blood Culture Pathology Tests Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Blood Culture Pathology Tests Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Blood Culture Pathology Tests Sales Value, (2026-2031) & (US$ Million)
 Table 31. Biobase Biotech Basic Information List
 Table 32. Biobase Biotech Description and Business Overview
 Table 33. Biobase Biotech Blood Culture Pathology Tests Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Biobase Biotech (2020-2025)
 Table 35. Biobase Biotech Recent Developments
 Table 36. Scenker Biological Technology Basic Information List
 Table 37. Scenker Biological Technology Description and Business Overview
 Table 38. Scenker Biological Technology Blood Culture Pathology Tests Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Scenker Biological Technology (2020-2025)
 Table 40. Scenker Biological Technology Recent Developments
 Table 41. Bulldog Bio Basic Information List
 Table 42. Bulldog Bio Description and Business Overview
 Table 43. Bulldog Bio Blood Culture Pathology Tests Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Bulldog Bio (2020-2025)
 Table 45. Bulldog Bio Recent Developments
 Table 46. Anaerobe Systems Basic Information List
 Table 47. Anaerobe Systems Description and Business Overview
 Table 48. Anaerobe Systems Blood Culture Pathology Tests Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Anaerobe Systems (2020-2025)
 Table 50. Anaerobe Systems Recent Developments
 Table 51. Himedia Laboratories Basic Information List
 Table 52. Himedia Laboratories Description and Business Overview
 Table 53. Himedia Laboratories Blood Culture Pathology Tests Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Himedia Laboratories (2020-2025)
 Table 55. Himedia Laboratories Recent Developments
 Table 56. Autobio Diagnostics Basic Information List
 Table 57. Autobio Diagnostics Description and Business Overview
 Table 58. Autobio Diagnostics Blood Culture Pathology Tests Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Autobio Diagnostics (2020-2025)
 Table 60. Autobio Diagnostics Recent Developments
 Table 61. Axiom Laboratories Basic Information List
 Table 62. Axiom Laboratories Description and Business Overview
 Table 63. Axiom Laboratories Blood Culture Pathology Tests Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Axiom Laboratories (2020-2025)
 Table 65. Axiom Laboratories Recent Developments
 Table 66. Iridica Basic Information List
 Table 67. Iridica Description and Business Overview
 Table 68. Iridica Blood Culture Pathology Tests Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Iridica (2020-2025)
 Table 70. Iridica Recent Developments
 Table 71. Biosystems Basic Information List
 Table 72. Biosystems Description and Business Overview
 Table 73. Biosystems Blood Culture Pathology Tests Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Biosystems (2020-2025)
 Table 75. Biosystems Recent Developments
 Table 76. BINDER GmBH Basic Information List
 Table 77. BINDER GmBH Description and Business Overview
 Table 78. BINDER GmBH Blood Culture Pathology Tests Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Blood Culture Pathology Tests Business of BINDER GmBH (2020-2025)
 Table 80. BINDER GmBH Recent Developments
 Table 81. Terumo Corporation Basic Information List
 Table 82. Terumo Corporation Description and Business Overview
 Table 83. Terumo Corporation Blood Culture Pathology Tests Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Terumo Corporation (2020-2025)
 Table 85. Terumo Corporation Recent Developments
 Table 86. BD Basic Information List
 Table 87. BD Description and Business Overview
 Table 88. BD Blood Culture Pathology Tests Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Blood Culture Pathology Tests Business of BD (2020-2025)
 Table 90. BD Recent Developments
 Table 91. BioMérieux Basic Information List
 Table 92. BioMérieux Description and Business Overview
 Table 93. BioMérieux Blood Culture Pathology Tests Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Blood Culture Pathology Tests Business of BioMérieux (2020-2025)
 Table 95. BioMérieux Recent Developments
 Table 96. Thermo Fisher Scientific Basic Information List
 Table 97. Thermo Fisher Scientific Description and Business Overview
 Table 98. Thermo Fisher Scientific Blood Culture Pathology Tests Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Thermo Fisher Scientific (2020-2025)
 Table 100. Thermo Fisher Scientific Recent Developments
 Table 101. Danaher Basic Information List
 Table 102. Danaher Description and Business Overview
 Table 103. Danaher Blood Culture Pathology Tests Products, Services and Solutions
 Table 104. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Danaher (2020-2025)
 Table 105. Danaher Recent Developments
 Table 106. Luminex Basic Information List
 Table 107. Luminex Description and Business Overview
 Table 108. Luminex Blood Culture Pathology Tests Products, Services and Solutions
 Table 109. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Luminex (2020-2025)
 Table 110. Luminex Recent Developments
 Table 111. Bruker Basic Information List
 Table 112. Bruker Description and Business Overview
 Table 113. Bruker Blood Culture Pathology Tests Products, Services and Solutions
 Table 114. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Bruker (2020-2025)
 Table 115. Bruker Recent Developments
 Table 116. Roche Basic Information List
 Table 117. Roche Description and Business Overview
 Table 118. Roche Blood Culture Pathology Tests Products, Services and Solutions
 Table 119. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Roche (2020-2025)
 Table 120. Roche Recent Developments
 Table 121. Mikroscan Technologies Basic Information List
 Table 122. Mikroscan Technologies Description and Business Overview
 Table 123. Mikroscan Technologies Blood Culture Pathology Tests Products, Services and Solutions
 Table 124. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Mikroscan Technologies (2020-2025)
 Table 125. Mikroscan Technologies Recent Developments
 Table 126. Labotronics Basic Information List
 Table 127. Labotronics Description and Business Overview
 Table 128. Labotronics Blood Culture Pathology Tests Products, Services and Solutions
 Table 129. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Labotronics (2020-2025)
 Table 130. Labotronics Recent Developments
 Table 131. Hardy Diagnostics Basic Information List
 Table 132. Hardy Diagnostics Description and Business Overview
 Table 133. Hardy Diagnostics Blood Culture Pathology Tests Products, Services and Solutions
 Table 134. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Hardy Diagnostics (2020-2025)
 Table 135. Hardy Diagnostics Recent Developments
 Table 136. OpGen Basic Information List
 Table 137. OpGen Description and Business Overview
 Table 138. OpGen Blood Culture Pathology Tests Products, Services and Solutions
 Table 139. Revenue (US$ Million) in Blood Culture Pathology Tests Business of OpGen (2020-2025)
 Table 140. OpGen Recent Developments
 Table 141. Meditech Technologie Basic Information List
 Table 142. Meditech Technologie Description and Business Overview
 Table 143. Meditech Technologie Blood Culture Pathology Tests Products, Services and Solutions
 Table 144. Revenue (US$ Million) in Blood Culture Pathology Tests Business of Meditech Technologie (2020-2025)
 Table 145. Meditech Technologie Recent Developments
 Table 146. Key Raw Materials Lists
 Table 147. Raw Materials Key Suppliers Lists
 Table 148. Blood Culture Pathology Tests Downstream Customers
 Table 149. Blood Culture Pathology Tests Distributors List
 Table 150. Research Programs/Design for This Report
 Table 151. Key Data Information from Secondary Sources
 Table 152. Key Data Information from Primary Sources
 Table 153. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Blood Culture Pathology Tests Product Picture
 Figure 2. Global Blood Culture Pathology Tests Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Blood Culture Pathology Tests Sales Value (2020-2031) & (US$ Million)
 Figure 4. Blood Culture Pathology Tests Report Years Considered
 Figure 5. Global Blood Culture Pathology Tests Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Blood Culture Pathology Tests Revenue in 2024
 Figure 7. Blood Culture Pathology Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Instruments Picture
 Figure 9. Consumables Picture
 Figure 10. Others Picture
 Figure 11. Global Blood Culture Pathology Tests Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 12. Global Blood Culture Pathology Tests Sales Value Market Share by Type, 2024 & 2031
 Figure 13. Product Picture of Bacteremia
 Figure 14. Product Picture of Fungemia
 Figure 15. Product Picture of Mycobacterial Detection
 Figure 16. Global Blood Culture Pathology Tests Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global Blood Culture Pathology Tests Sales Value Market Share by Application, 2024 & 2031
 Figure 18. North America Blood Culture Pathology Tests Sales Value (2020-2031) & (US$ Million)
 Figure 19. North America Blood Culture Pathology Tests Sales Value by Country (%), 2024 VS 2031
 Figure 20. Europe Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 21. Europe Blood Culture Pathology Tests Sales Value by Country (%), 2024 VS 2031
 Figure 22. Asia Pacific Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 23. Asia Pacific Blood Culture Pathology Tests Sales Value by Region (%), 2024 VS 2031
 Figure 24. South America Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 25. South America Blood Culture Pathology Tests Sales Value by Country (%), 2024 VS 2031
 Figure 26. Middle East & Africa Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 27. Middle East & Africa Blood Culture Pathology Tests Sales Value by Country (%), 2024 VS 2031
 Figure 28. Key Countries/Regions Blood Culture Pathology Tests Sales Value (%), (2020-2031)
 Figure 29. United States Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 30. United States Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
 Figure 31. United States Blood Culture Pathology Tests Sales Value by Application (%), 2024 VS 2031
 Figure 32. Europe Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Europe Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
 Figure 34. Europe Blood Culture Pathology Tests Sales Value by Application (%), 2024 VS 2031
 Figure 35. China Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 36. China Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
 Figure 37. China Blood Culture Pathology Tests Sales Value by Application (%), 2024 VS 2031
 Figure 38. Japan Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 39. Japan Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
 Figure 40. Japan Blood Culture Pathology Tests Sales Value by Application (%), 2024 VS 2031
 Figure 41. South Korea Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 42. South Korea Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
 Figure 43. South Korea Blood Culture Pathology Tests Sales Value by Application (%), 2024 VS 2031
 Figure 44. Southeast Asia Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 45. Southeast Asia Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
 Figure 46. Southeast Asia Blood Culture Pathology Tests Sales Value by Application (%), 2024 VS 2031
 Figure 47. India Blood Culture Pathology Tests Sales Value, (2020-2031) & (US$ Million)
 Figure 48. India Blood Culture Pathology Tests Sales Value by Type (%), 2024 VS 2031
 Figure 49. India Blood Culture Pathology Tests Sales Value by Application (%), 2024 VS 2031
 Figure 50. Blood Culture Pathology Tests Industrial Chain
 Figure 51. Blood Culture Pathology Tests Manufacturing Cost Structure
 Figure 52. Channels of Distribution (Direct Sales, and Distribution)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed

Description

The global market for Blood Culture Pathology Tests was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

A blood culture is a medical laboratory test used to detect the presence of microorganisms, such as bacteria and fungi, in a patient"s bloodstream.

North American market for Blood Culture Pathology Tests was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Blood Culture Pathology Tests was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Blood Culture Pathology Tests was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Blood Culture Pathology Tests include Biobase Biotech, Scenker Biological Technology, Bulldog Bio, Anaerobe Systems, Himedia Laboratories, Autobio Diagnostics, Axiom Laboratories, Iridica, Biosystems, BINDER GmBH, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Blood Culture Pathology Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood Culture Pathology Tests by region & country, by Type, and by Application.

The Blood Culture Pathology Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Culture Pathology Tests.

Market Segmentation

Related Reports

Global Blood Culture Pathology Tests Market Research Report 2024
A blood culture is a medical laboratory test used to detect the presence of microorganisms, such as bacteria and fungi, in a patient's bloodstream.
Published: 2024-01-17
Pages: 102
USD 2900.00
(Single User License)
Global Blood Culture Pathology Tests Market Research Report 2025
The global market for Blood Culture Pathology Tests was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 101
USD 2900.00
(Single User License)
Global Blood Culture Pathology Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Blood Culture Pathology Tests market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 113
USD 4250.00
(Single User License)
Global Blood Culture Pathology Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Blood Culture Pathology Tests market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 162
USD 4900.00
(Single User License)
Global Blood Culture Pathology Tests Market Research Report 2026
The global Blood Culture Pathology Tests market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 157
USD 2900.00
(Single User License)
Blood Culture Pathology Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Blood Culture Pathology Tests was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 159
USD 3950.00
(Single User License)

Global Blood Culture Pathology Tests Market Research Report 2024
A blood culture is a medical laboratory test used to detect the presence of microorganisms, such as bacteria and fungi, in a patient's bloodstream.
Published: 2024-01-17
Pages: 102
USD 2900.00 ()
Global Blood Culture Pathology Tests Market Research Report 2025
The global market for Blood Culture Pathology Tests was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 101
USD 2900.00 ()
Global Blood Culture Pathology Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Blood Culture Pathology Tests market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 113
USD 4250.00 ()
Global Blood Culture Pathology Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Blood Culture Pathology Tests market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 162
USD 4900.00 ()
Global Blood Culture Pathology Tests Market Research Report 2026
The global Blood Culture Pathology Tests market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 157
USD 2900.00 ()
Blood Culture Pathology Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Blood Culture Pathology Tests was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 159
USD 3950.00 ()